Use of TRH in the Fetus to Advance Lung Maturity
Respiratory distress syndrome (RDS) secondary to prematurity is a leading cause of perinatal mortality. The incidence of RDS increases as the gestational age at birth declines and occurs in approximately two thirds of infants born at 29–30 weeks gestational age (1). The functional immaturity of the fetal lung is both anatomic and biochemical. The most obvious abnormality is insufficient production of surfactant by the Type II alveolar cells. Composed of proteins and phospholipids and packaged in granules secreted by the alveolar lining cells, surfactant lines the air-tissue interface of the alveoli and decreases surface tension. This decrease in surface tension allows the alveoli to remain expanded in the absence of continuous airway pressure.
KeywordsThyroid Hormone Respiratory Distress Syndrome Fetal Lung Lung Maturation Combine Therapy Group
Unable to display preview. Download preview PDF.
- 2.Colaborative Group on antenatal Steroid Therapy: Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 141: 276–86 (1981).Google Scholar
- 17.Schellenberg JC, Liggins GC, Manzai M, et al: Synergistic hormonal effect on lung maturation in fetal sheep. J Appl Physiol 65: 84–100 (1988).Google Scholar